HO-1 Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-HO-1 antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityHO-1
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman, mouse, rat, dog, rabbit, sheep
Isotypen/a
FormatProtein A purified
Size0.05 mg, 1 mg
Concentrationn/a
ApplicationsFlow Cytometry (FC/FACS), Immunocytochemistry (ICC), Immunohistochemistry (IHC) Paraffin, Western Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionRecognizes human, mouse, rat, dog, rabbit, and sheep HO-1. Detects a band of ~32kDa by Western blot. Heme Oxygenase-1 (HO-1) also known as Hsp32, is the inducible isoform of heme oxygenase that catalyzes the NADPH, oxygen, and cytochrome P450 reductase dependent oxidation of heme to carbon monoxide, ferrous iron and biliverdin which is rapidly reduced to bilirubin. These products of the HO reaction have important physiological effects: carbon monoxide is a potent vasodilator and has been implicated to be a physiological regulator of cGMP and vascular tone; biliverdin and its product bilirubin are potent antioxidants; free iron increases oxidative stress and regulates the expression of many mRNAs (e.g., DCT-1, ferritin and transferring rec
ImmunogenImmunogen: Recombinant rat HO-1 (Hsp32) lacking the membrane spanning region.
Other Names[HMOX1; Hsp32; Heat shock protein 32; Heme oxygenase 1], [Hmox1; Hmox1; Ho1; Heox; Hmox; Ho-1; HEOXG; hsp32; HO-1]
Gene, Accession #[HO-1], Gene ID: 24451, NCBI: P06762.1, UniProt: P06762
Catalog #MBS565261
Price$250, $1740
Order / More InfoHO-1 Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.